Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
NCT ID:
NCT02622750
Eligibility Criteria:
Inclusion Criteria:
* age\<65 years
* acute DeBakkey I aortic dissection is confirmed by CTA
* cardiac function is NYHA I-II
* the onset time\< 2 weeks
* the patient or family members can understand the research plan and will participate in this study and provide a written informed consent
Exclusion Criteria:
* Dissection involved the superior mesenteric artery, renal artery and coronary artery, which affect the body's viscera function seriously. The principal researcher from different centre need judge the patients' condition.
* there is a serious complication of nervous system, such as coma, paraplegia, etc
* pregnant or lactating women
* anyone with severe emphysema, interstitial pneumonia or ischemic heart disease cannot tolerate surgery
* subjects with contraindications of heart surgery, anesthesia and extracorporeal circulation
* subjects had significant or progressive of heart disease, according to the experience of the researchers,whose life expectancy is less than 1 year, or placement of triple- branched stent graft will induce unacceptable risk to the subjects
* anyone with serious mental illness, drug abuse, alcoholism, prison inmates, a lack of ability to care for, or can not express the informed consent
* subjects are incompliance or can't complete the research
* anyone is involved in the other clinical trial
* other reasons are not suitable for clinical trials, according to the researchers
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT02622750
Study Brief:
Protocol Section:
NCT02622750